Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

ABOSABOS
Showing 8 of 17 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in ACUMEN PHARMACEUTICALS INC

TWO SIGMA INVESTMENTS, LP holds 622,882 shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $1.7M as of 2026-Q2. The position was increased (+17.4% shares). ABOS represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$1.7M

Current Shares

622,882

Total Value Change

+$895,518

Total Shares Change

+313,375

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
622,882
+17.4%
$1.7M0.0%$2.67
30
2026-Q1
Increased
530,812
+270.6%
$1.3M0.0%$2.36
41
2025-Q4
Decreased
143,221
-28.2%
$302,1960.0%$2.11
0
2025-Q3
Decreased
199,446
-0.7%
$341,0530.0%$1.71
0
2025-Q2
Decreased
200,785
-13.6%
$232,9110.0%$1.16
0
2025-Q1
Decreased
232,293
-22.9%
$255,5220.0%$1.10
0
2024-Q4
Decreased
301,268
-2.7%
$518,1810.0%$1.72
0
2024-Q3
Decreased
309,507
-0.4%
$767,5770.0%$2.48
0

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used